What is Annovis Bio Inc?
, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 44.12M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 15,000,000 shares $5.0M |
| 3-6months | 0 | 0 |
| 6-9months | 0 | 4790,144 shares $1.6M |
| 9-12months | 0 | 684,200 shares $354k |